Use of Rituximab for Refractory Cytopenias Associated With Autoimmune Lymphoproliferative Syndrome (ALPS)
Pediatric Blood and Cancer - United States
doi 10.1002/pbc.21965
Full Text
Open PDFAbstract
Available in full text
Date
July 1, 2009
Authors
Publisher
Wiley